Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Apros Therapeutics to Present Interim Clinical Data from a Phase 1 Study Evaluating APR003 at the…
SAN DIEGO--(BUSINESS WIRE)--Apros Therapeutics, Inc., a clinical stage biotechnology company focused on tissue-targeted Toll-Like Receptor 7 (TLR7) agonists for the treatment of advanced cancers and infectious diseases, today announced…